Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Indinavir sulphate 250 mg, 500 mg equivalent to 200 mg, 400 mg indinavir respectively Capsules Merck & Co Inc., Elkton, Virginia, United States of America Crixivan Note: This provisional consent is valid for two (2) years from the date of publication of this notice. Dated this 16th day of September 1996. HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.